TIAA CREF Investment Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $7.65M | Sell |
65,141
-3,733
| -5% | -$438K | 0.01% | 1188 |
|
|
2018
Q4 | $7.5M | Buy |
68,874
+2,418
| +4% | +$263K | 0.01% | 1107 |
|
|
2018
Q3 | $8.5M | Sell |
66,456
-25,201
| -27% | -$3.22M | 0.01% | 1203 |
|
|
2018
Q2 | $10.4M | Sell |
91,657
-65,355
| -42% | -$7.39M | 0.01% | 1137 |
|
|
2018
Q1 | $17.6M | Buy |
157,012
+17,631
| +13% | +$1.98M | 0.01% | 818 |
|
|
2017
Q4 | $20.6M | Sell |
139,381
-1,377
| -1% | -$204K | 0.01% | 779 |
|
|
2017
Q3 | $16.5M | Sell |
140,758
-1,989
| -1% | -$233K | 0.01% | 855 |
|
|
2017
Q2 | $18.5M | Sell |
142,747
-85,161
| -37% | -$11M | 0.01% | 800 |
|
|
2017
Q1 | $30.9M | Buy |
227,908
+1,424
| +0.6% | +$193K | 0.02% | 590 |
|
|
2016
Q4 | $32.5M | Buy |
226,484
+23,049
| +11% | +$3.31M | 0.02% | 569 |
|
|
2016
Q3 | $24K | Buy |
203,435
+23,660
| +13% | +$2.79K | 0.02% | 704 |
|
|
2016
Q2 | $19M | Buy |
179,775
+1,465
| +0.8% | +$155K | 0.01% | 747 |
|
|
2016
Q1 | $19.9M | Sell |
178,310
-203,839
| -53% | -$22.7M | 0.02% | 746 |
|
|
2015
Q4 | $59.8M | Sell |
382,149
-25,165
| -6% | -$3.94M | 0.04% | 399 |
|
|
2015
Q3 | $53.5M | Sell |
407,314
-33,432
| -8% | -$4.39M | 0.04% | 431 |
|
|
2015
Q2 | $76.7M | Buy |
440,746
+219,465
| +99% | +$38.2M | 0.05% | 360 |
|
|
2015
Q1 | $38.2M | Buy |
221,281
+106,798
| +93% | +$18.4M | 0.03% | 563 |
|
|
2014
Q4 | $14.8M | Buy |
114,483
+12,341
| +12% | +$1.6M | 0.01% | 884 |
|
|
2014
Q3 | $13.1M | Sell |
102,142
-22,349
| -18% | -$2.88M | 0.01% | 931 |
|
|
2014
Q2 | $11M | Sell |
124,491
-1,492
| -1% | -$132K | 0.01% | 1090 |
|
|
2014
Q1 | $11.8M | Sell |
125,983
-232,084
| -65% | -$21.8M | 0.01% | 1034 |
|
|
2013
Q4 | $40.5M | Sell |
358,067
-28,065
| -7% | -$3.17M | 0.03% | 549 |
|
|
2013
Q3 | $30.4M | Sell |
386,132
-17,970
| -4% | -$1.42M | 0.02% | 611 |
|
|
2013
Q2 | $26.6M | Buy |
+404,102
| New | +$26.6M | 0.02% | 620 |
|